These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22154207)

  • 1. Acoustic phase shift: objective evidence for intralabyrinthine pressure disturbance in Menière's disease provided by otoacoustic emissions.
    Mom T; Montalban A; Bascoul A; Gilain L; Avan P
    Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Feb; 129(1):17-21. PubMed ID: 22154207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glycerol intake and body tilt on otoacoustic emissions reflect labyrinthine pressure changes in Menière's disease.
    Mom T; Gilain L; Avan P
    Hear Res; 2009 Apr; 250(1-2):38-45. PubMed ID: 19450433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unstable distortion-product otoacoustic emission phase in Menière's disease.
    Avan P; Giraudet F; Chauveau B; Gilain L; Mom T
    Hear Res; 2011 Jul; 277(1-2):88-95. PubMed ID: 21426928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive measurements of intralabyrinthine pressure changes by electrocochleography and otoacoustic emissions.
    Büki B; Giraudet F; Avan P
    Hear Res; 2009 May; 251(1-2):51-9. PubMed ID: 19233252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the differential diagnosis of Ménière's disease using low-frequency acoustic biasing of the 2f1-f2 DPOAE.
    Brown DJ; Gibson WP
    Hear Res; 2011 Dec; 282(1-2):119-27. PubMed ID: 21944944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evoked otoacoustic emissions in patients with Ménière's disease.
    de Kleine E; Mateijsen DJ; Wit HP; Albers FW
    Otol Neurotol; 2002 Jul; 23(4):510-6. PubMed ID: 12170154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of vestibular aqueduct and inner ear pressure in Ménière's disease and the normal population.
    Sennaroglu L; Yilmazer C; Basaran F; Sennaroglu G; Gursel B
    Laryngoscope; 2001 Sep; 111(9):1625-30. PubMed ID: 11568617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of patients with Ménière's disease using otoacoustic emissions.
    van Huffelen WM; Mateijsen NJ; Wit HP
    Audiol Neurootol; 1998; 3(6):419-30. PubMed ID: 9732134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endolymphatic hydrops and blood-labyrinth barrier in Ménière's disease.
    Tagaya M; Yamazaki M; Teranishi M; Naganawa S; Yoshida T; Otake H; Nakata S; Sone M; Nakashima T
    Acta Otolaryngol; 2011 May; 131(5):474-9. PubMed ID: 21198346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The application of otoacoustic emission registration in the diagnosis of Meniere's disease].
    Pal'chun VT; Levina IuV
    Vestn Otorinolaringol; 1999; (6):5-8. PubMed ID: 10596591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear microphonics in Ménière's disease.
    Ge NN; Shea JJ; Orchik DJ
    Am J Otol; 1997 Jan; 18(1):58-66. PubMed ID: 8989953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss.
    Inoue Y; Kanzaki J; O-Uchi T; Ogawa K; Ogata A; Yoshihara S; Satoh Y
    Auris Nasus Larynx; 1997 Apr; 24(2):143-9. PubMed ID: 9134136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of endolymphatic hydrops with low tone masked otoacoustic emissions].
    Nubel K; Kabudwand E; Scholz G; Mrowinski D
    Laryngorhinootologie; 1995 Nov; 74(11):651-6. PubMed ID: 8561815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors.
    Kitahara T; Doi K; Maekawa C; Kizawa K; Horii A; Kubo T; Kiyama H
    J Neuroendocrinol; 2008 Dec; 20(12):1295-300. PubMed ID: 19094077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered frequency dynamics of cervical and ocular vestibular evoked myogenic potentials in patients with Ménière's disease.
    Sandhu JS; Low R; Rea PA; Saunders NC
    Otol Neurotol; 2012 Apr; 33(3):444-9. PubMed ID: 22334161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops.
    Magliulo G; Cianfrone G; Triches L; Altissimi G; D'Amico R
    Laryngoscope; 2001 Jan; 111(1):102-9. PubMed ID: 11192876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease.
    Sakashita T; Shibata T; Yamane H; Hikawa C
    Acta Otolaryngol Suppl; 2004 Oct; (554):26-9. PubMed ID: 15513506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic significance of transiently evoked otoacoustic emissions in meniere's disease].
    Li Q; Zhong N
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Oct; 13(10):435-7. PubMed ID: 12541392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.